YOLFTbeta
Zhongchao Inc

Zhongchao Inc

ZCMD · NASDAQ · Healthcare / Health Information Services

0.90USD-0.03 (-3.23%)

Price History

Full chart

Market Stats

Previous Close0.93
Open0.9301
Day Range0.89 – 0.9498
52-Week Range0.712 – 967.20
Volume31.85K
Market Cap7.99M
P/E (TTM)0.00
Forward P/E0.00
EPS-172.05
Dividend Yield0.00%
Beta-0.05
50-Day Avg1.06
200-Day Avg136.68

About

Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Weiguang Yang
  • Employees33
  • Headquarters841 Yan?an Middle Road, Shanghai, China, 200040, USA
  • Websitehttps://www.izcmd.com

Leadership

  • Mr. Weiguang YangFounder, Chairman, President & CEO · b. 1982
  • Ms. Pei XuCFO, Secretary & Director · b. 1982

Financials

Income Statement

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue9.82M12.87M14.88M17.99M16.30M14.15M19.43M15.86M11.37M
Growth (%)-+31.07%+15.68%+20.88%-9.41%-13.16%+37.33%-18.37%-28.30%
Cost of Revenue3.97M4.46M4.66M6.12M6.86M7.79M10.92M6.95M6.54M
Gross Profit5.85M8.41M10.23M11.87M9.44M6.36M8.51M8.91M4.83M
Gross Margin59.56%65.36%68.72%65.99%57.92%44.92%43.80%56.18%42.47%
Operating Expense4.80M5.13M6.58M7.38M9.76M9.31M21.80M9.25M11.02M
Operating Income1.05M3.27M3.64M4.49M-320.74K-2.95M-13.28M-341.27K-6.19M
Operating Margin10.68%25.45%24.47%24.96%-1.97%-20.88%-68.35%-2.15%-54.43%
EBITDA1.06M3.30M3.88M4.89M592.22K-1.82M-4.49M87.95K-5.45M
EBITDA Margin10.85%25.68%26.09%27.20%3.63%-12.86%-23.09%0.55%-47.89%
Net Income1.53M3.02M4.05M4.46M238.66K-2.94M-11.34M-643.23K-6.31M
Net Income Margin15.58%23.47%27.19%24.78%1.46%-20.78%-58.33%-4.05%-55.47%
R&D943.25K1.45M864.32K816.55K758.88K411.52K514.41K252.45K8.09K
R&D as % of Total Revenue9.61%11.25%5.81%4.54%4.66%2.91%2.65%1.59%0.07%
Interest Expense00791.67K453.81K209.99K285.88K---
Interest Expense % of Total Revenue0.00%0.00%5.32%2.52%1.29%2.02%---

Balance Sheet

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.98M14.05M17.74M34.82M36.27M38.61M24.42M25.88M24.32M
Total Liabilities1.56M2.33M2.40M2.98M3.70M5.60M3.38M1.73M1.72M
Total Equity5.21M11.41M15.39M31.83M32.57M29.93M18.01M20.84M18.63M
Cash2.98M7.92M7.83M15.07M13.91M11.52M7.55M7.84M8.10M
Total Debt-727.22K292.94K62.16K201.56K1.70M808.16K57.52K26.08K
Net Debt-2.98M-7.19M-7.54M-15.01M-13.71M-9.82M-6.74M-7.78M-8.07M

Cash Flow

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-537.65K1.31M1.41M-1.04M2.86M-661.74K54.23K-1.47M845.39K
Investing Cash Flow-1.84M-504.05K-203.07K-4.09M-4.02M-3.35M-3.75M-1.81M-826.60K
Financing Cash Flow2.73M4.34M-1.19M11.50M01.85M03.84M0
Capital Expenditure32.22K668.07K1.31M160.60K1.80M1.86M839.74K3.05M152.56K
Free Cash Flow-569.87K644.58K95.08K-1.20M1.06M-2.52M-785.51K-4.52M692.83K
FCF to OCF105.99%49.11%6.75%115.47%37.11%381.28%-1448.50%306.70%81.95%

Earnings

Report DateMar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Nov 21, 2019Mar 31, 2020May 8, 2020Sep 21, 2020Dec 31, 2020Mar 31, 2021Apr 30, 2021Nov 12, 2021May 9, 2022Nov 1, 2024Apr 25, 2025Sep 29, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.010.010.060.060.040.040.050.150.030.190.060.060.020.180.04-0.030.03-0.09-0.04
Surprise-------------------
Timing-------------------

Key Statistics & Ratios

Market Cap7.99M
Enterprise Value-5.07M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.70
Price / Book0.47
EPS-172.05
Book Value6.39
Revenue (TTM)11.37M
Gross Profit (TTM)5.12M
EBITDA-5.90M
Profit Margin-55.47%
Operating Margin-92.00%
Return on Equity-24.88%
Return on Assets-15.47%
Shares Outstanding8.67M
Shares Float14.56K
Beta-0.05
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.01%
Insiders
28.85%
Retail / Other
71.14%

Top Institutional Holders

  • XTX Topco Ltd
    11.87K0.31%
  • Tower Research Capital LLC
    1100.00%
  • UBS Group AG
    00.00%
  • Susquehanna International Group, LLP
    00.00%
  • TWO SIGMA SECURITIES, LLC
    00.00%
  • Citadel Advisors Llc
    00.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    740.00%

Stock Splits

  • Jun 29, 20261:3
  • Jun 8, 20261:31
  • Mar 2, 20261:8
  • Feb 29, 20241:10